Simran Farms Limited (BOM:519566)

Sage Therapeutics Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	58.96	3.84	35.8	102.9	125.81
Depreciation & Amortization	18.67	18.04	20.31	21.52	21.65
Loss (Gain) From Sale of Assets	-	-	-4.19	-26.57	-0.31
Other Operating Activities	23.85	8.06	-0.9	-22.07	74.65
Change in Accounts Receivable	-35.15	-35.56	-19.02	-4.91	21.53
Change in Inventory	-561.14	-122.26	-212.45	-117.05	5.79
Change in Accounts Payable	312.82	171.8	86.22	23.52	-143.27
Change in Other Net Operating Assets	70.04	37.91	26.64	-1.48	-0.26
Operating Cash Flow	-111.97	81.82	-67.59	-24.13	105.59
Capital Expenditures	-24.48	-13.67	-40.34	-32.84	-14.28
Sale of Property, Plant & Equipment	-	-	4.35	27.12	3.45
Other Investing Activities	0.16	0.12	0.15	1.42	-
Investing Cash Flow	-24.27	-13.64	-35.94	-4.72	-10.84
Long-Term Debt Issued	0.98	-	8.88	0.06	-
Total Debt Issued	0.98	-	8.88	0.06	-
Long-Term Debt Repaid	-5.07	-5.11	-2.53	-	-17.06
Total Debt Repaid	-5.07	-5.11	-2.53	-	-17.06
Net Debt Issued (Repaid)	-4.09	-5.11	6.35	0.06	-17.06
Other Financing Activities	38.9	-1.91	-1.53	-2.98	-2.03
Financing Cash Flow	34.81	-7.01	4.82	-2.92	-19.09
Net Cash Flow	-101.42	61.18	-98.72	-31.77	75.66
Free Cash Flow	-136.45	68.15	-107.93	-56.97	91.31
Free Cash Flow Margin	-1.63%	1.40%	-2.94%	-1.45%	2.83%
Free Cash Flow Per Share	-33.44	17.97	-28.46	-15.03	24.08
Cash Interest Paid	0.56	1.91	1.53	2.98	2.03
Cash Income Tax Paid	6.61	2.34	4.57	22.55	20.74
Levered Free Cash Flow	-222.75	5.14	-126.47	-72.92	46.53
Unlevered Free Cash Flow	-216.09	16.16	-116.06	-62.6	54.37
Change in Net Working Capital	267.54	3.92	128.11	108.21	98.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.